ELMD (Electromed) ROE % Adjusted to Book Value: 6.44% (As of Mar. 2026)

Electromed ELMD +3.52% 91 ROE % Adjusted to Book Value is 6.44% as of Mar. 2026. GuruFocus rates ELMD with a GF Score™ of 91/100 and a GF Value™ of $25.16 (Significantly Overvalued). The stock has 5 warning signs investors should review.

Electromed's ROE % for the quarter that ended in Mar. 2026 was 25.39%. Electromed's PB Ratio for the quarter that ended in Mar. 2026 was 3.94. Electromed's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 was 6.44%.

Electromed ROE % Adjusted to Book Value Related Terms

Electromed ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Electromed's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Electromed ROE % Adjusted to Book Value Chart

Electromed Annual Data

Trend

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Jun25

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

2.54

2.90

3.63

4.31

4.04

Electromed Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															3.74	4.76	4.23	4.61	6.44

ELMD vs MASS, SI, CV: ROE % Adjusted to Book Value Comparison

For the Medical Devices subindustry, Electromed's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Electromed ROE % Adjusted to Book Value vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Electromed's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Electromed's ROE % Adjusted to Book Value falls into.

Save Embed

91GF Score

Electromed Inc ELMD

ROE % Adjusted to Book Value is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Electromed ROE % Adjusted to Book Value Calculation

Electromed's ROE % Adjusted to Book Value for the fiscal year that ended in Jun. 2025 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	17.18%	/	4.25
	=	4.04%

Electromed's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	25.39%	/	3.94
	=	6.44%

Frequently Asked Questions Learn more about ROE % Adjusted to Book Value →

What does a ROE % Adjusted to Book Value of 6.44% mean?

Electromed (ELMD) has a ROE % Adjusted to Book Value of 6.44% as of Mar. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Electromed and its competitors.

Is Electromed's ROE % Adjusted to Book Value too high?

Electromed's current ROE % Adjusted to Book Value is 6.44%. Overall, Electromed has a GF Score™ of 91/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.

How does Electromed's ROE % Adjusted to Book Value compare to MASS and SI?

Electromed's ROE % Adjusted to Book Value of 6.44% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good ROE % Adjusted to Book Value for a Medical Devices & Instruments company?

A good ROE % Adjusted to Book Value depends on the Medical Devices & Instruments industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high ROE % Adjusted to Book Value mean?

A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Electromed and its competitors. Electromed's current ROE % Adjusted to Book Value is 6.44%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Electromed stock overvalued right now?

Based on GuruFocus' analysis, Electromed (ELMD) is currently considered Significantly Overvalued. The stock's GF Value™ is $25.16, compared to a current price of $41.46 — trading 64.8% above its estimated fair value. The current ROE % Adjusted to Book Value is 6.44%. Electromed's overall GF Score™ is 91/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is ROE % Adjusted to Book Value calculated?

ROE % Adjusted to Book Value is calculated from a company's financial statements. For Electromed (ELMD), the current ROE % Adjusted to Book Value is 6.44% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Electromed (ELMD) Overvalued in 2026?

Based on GuruFocus' analysis, Electromed stock appears to be overvalued. The current stock price of $41.46 is trading 64.8% above its estimated GF Value™ of $25.16. GuruFocus considers Electromed to be Significantly Overvalued.

Key valuation signals for ELMD:

ROE % Adjusted to Book Value: 6.44%
GF Value™: $25.16 vs. price of $41.46 (64.8% above fair value)
GF Score™: 91/100 with 5 warning signs

No single metric tells the full story. See the ELMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Electromed Business Description

Industry Healthcare Medical Devices & Instruments

Comparable Companies MASS SI CV SENS SGHT QSI DCTH OFIX VMD CLPT ABT SYK MDT BSX EW XTER:SHL DXCM GEHC SZSE:300760 XAMS:PHIA

Address 500 Sixth Avenue NW, New Prague, MN, USA, 56071

Website https://www.smartvest.com

Electromed Inc is a United States-based company that develops, manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective airway clearance therapy.

91GF Score

Get the complete analysis for ELMD

ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$41.46

Price

$25.16

GF Value

View ELMD Analysis

See ROE % Adjusted to Book Value data for all stocks →